SCHEMBL23867474

SCHEMBL23867474

O=C(Cc1cccs1)Nc1ccc(Nc2nc(N3CCN(CCO)CC3)nc3nccnc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 9/20 0.51
▸ POLB P06746 5/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ HTR2A P28223 6/20 0.44
▸ HTR2C P28335 1/20 0.43
▸ DRD3 P35462 1/20 0.43
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ BLM P54132 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ PKM P14618 1/20 0.42
▸ CTDSP1 Q9GZU7 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867534 0.83 SRC (0.47) SRCHTR2AHTR2CDRD3
SCHEMBL23867515 0.83 POLB (0.47) SRCPOLBNPC1RAB9AMAPT
SCHEMBL23867514 0.83 POLB (0.50) SRCPOLBNPC1RAB9AMAPT
SCHEMBL23867525 0.82 HTR2A (0.49) SRCPOLBNPC1RAB9AMAPT
SCHEMBL23867486 0.80 SRC (0.49) SRCPOLBMAPTHTR2AHTR2C
SCHEMBL23867479 0.79 POLB (0.49) POLBNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL23867579 0.77 SRC (0.40) SRCPOLBNPC1RAB9AMAPT
SCHEMBL23867478 0.76 SRC (0.53) SRCHTR2AHTR2CDRD3
SCHEMBL23867532 0.73 SRC (0.53) SRCHTR2AHTR2CDRD3
SCHEMBL23867516 0.72 POLB (0.53) POLBNPC1RAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback